Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Capital Expenditures: 2018-2024

Historic Capital Expenditures for Eton Pharmaceuticals (ETON) over the last 6 years, with Dec 2024 value amounting to $26,000.

  • Eton Pharmaceuticals' Capital Expenditures was N/A to $284,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $322,000, marking a year-over-year change of. This contributed to the annual value of $26,000 for FY2024, which is N/A change from last year.
  • Per Eton Pharmaceuticals' latest filing, its Capital Expenditures stood at $26,000 for FY2024, which was down 31.58% from $38,000 recorded in FY2022.
  • Over the past 5 years, Eton Pharmaceuticals' Capital Expenditures peaked at $50,000 during FY2020, and registered a low of $9,000 during FY2021.
  • Its 2-year average for Capital Expenditures is $32,000, with a median of $32,000 in 2022.
  • As far as peak fluctuations go, Eton Pharmaceuticals' Capital Expenditures crashed by 95.44% in 2020, and later soared by 322.22% in 2022.
  • Eton Pharmaceuticals' Capital Expenditures (Yearly) stood at $50,000 in 2020, then tumbled by 82.00% to $9,000 in 2021, then surged by 322.22% to $38,000 in 2022, then reached $26,000 in 2024.